Functional Vision With ACRYSOF® IQ IOLs Blue Light Filtration
| Status: | Completed |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 65 - 75 |
| Updated: | 3/16/2015 |
| Start Date: | October 2014 |
| End Date: | March 2015 |
| Contact: | Alcon Call Center |
| Email: | alcon.medinfo@alcon.com |
| Phone: | 1-888-451-3937 |
Functional Benefit With ACRYSOF® Natural Chromophore
The purpose of this study is to compare the reaction time of subjects with ACRYSOF® IQ
intraocular lenses (IOLs) to subjects with clear IOLs when exposed to glare. This study will
enroll subjects previously implanted with either ACRYSOF® IQ IOLs or clear IOLs in both eyes
for at least 3 months.
intraocular lenses (IOLs) to subjects with clear IOLs when exposed to glare. This study will
enroll subjects previously implanted with either ACRYSOF® IQ IOLs or clear IOLs in both eyes
for at least 3 months.
Subjects will complete 2 visits to the investigational site.
Inclusion Criteria:
- Pseudophakes with ACRYSOF® IQ monofocal IOLs or clear (no blue light filter) IOLs in
both eyes for at least 3 months.
- Willing and able to understand and sign an informed consent form.
- Corrected visual acuity (CVA) of 20/40 or better.
- Have a valid driver's license.
- Depth perception of at least 100 arc seconds.
- Other protocol-specified inclusion criteria may apply.
Exclusion Criteria:
- Ocular pathology, degeneration, or media opacity.
- Color vision defect.
- Use of ocular or systemic medications that impact macular pigment density or reaction
time, including but not limited to, lutein, zeaxanthin, barbiturates, tranquilizers
or amphetamines.
- System conditions affecting connective tissue or sensory-motor coordination.
- Other protocol-specified exclusion criteria may apply.
We found this trial at
1
site
Alcon Call Center Alcon is helping people see the world better through advanced surgical, pharmaceutical...
Click here to add this to my saved trials
